Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, 55 West 125th Street, New York, NY, 10027, USA.
CUNY Institute for Implementation Science in Population Health (ISPH), New York, NY, USA.
Prev Sci. 2019 Jan;20(1):168-177. doi: 10.1007/s11121-019-0985-y.
Since FDA approval in 2012, HIV pre-exposure prophylaxis (PrEP) has been adopted by key populations, including gay and bisexual men (GBM), to reduce their HIV transmission risk. Given that PrEP is optimally effective when taken as prescribed, it is critical to understand the adherence strategies GBM use. We conducted one-on-one, semi-structured interviews with GBM taking PrEP in 2015-2016 (n = 103). Using thematic analysis, we identified six adherence strategies, with most participants (84.3%) utilizing multiple strategies to maintain adequate adherence: (1) integrating PrEP into part of a daily routine, (2) using a pillbox, (3) cognitive strategies/visual cues, (4) setting recurring smartphone alarms or reminders, (5) keeping medication on oneself at all times, and (6) partner or peer support for reminders and/or pill sharing. Overall, participants reported high PrEP adherence (M = 1.6 missed doses in the prior 30 days), though nearly all described missing at least one dose unintentionally in the past. Participants credited their high levels of adherence in part to the strategies they adopted. Providers working with GBM prescribed PrEP, especially patients reporting difficulties with adherence, might consider recommending any or all of the six strategies described in this study.
自 2012 年 FDA 批准以来,艾滋病毒暴露前预防 (PrEP) 已被包括男同性恋和双性恋者 (GBM) 在内的关键人群采用,以降低他们的艾滋病毒传播风险。鉴于 PrEP 按规定服用时效果最佳,因此了解 GBM 采用的服用策略至关重要。我们在 2015-2016 年对正在服用 PrEP 的 GBM 进行了一对一的半结构化访谈(n=103)。通过主题分析,我们确定了六种服用策略,大多数参与者(84.3%)采用了多种策略来保持足够的服用依从性:(1)将 PrEP 纳入日常生活的一部分,(2)使用药盒,(3)认知策略/视觉提示,(4)设置定期智能手机警报或提醒,(5)始终随身携带药物,以及(6)伴侣或同伴提供提醒和/或分享药物。总体而言,参与者报告了较高的 PrEP 服用依从性(过去 30 天内漏服 1.6 剂),尽管几乎所有人都在过去描述过至少一次非故意漏服。参与者将他们的高服用依从性部分归功于他们采用的策略。与接受 PrEP 处方的 GBM 合作的提供者,尤其是报告服用依从性困难的患者,可能会考虑推荐本研究中描述的六种策略中的任何一种或全部。